The US Food and Drug Administration (FDA) is set to restrict the Covid-19 booster doses to older adults and those at risk of ...

The 5th Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) will gather industry leaders in Vösendorf, Austria on ...

Companies remain exposed to heightened risks between the world’s largest markets and are cautious of the stability of ...

The US Department of Health and Human Services (HHS) said it is “taking immediate steps” to implement a recent Executive ...

The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...

All participants will initially undergo a run-in period on standardised medium-dose ICS/LABA to confirm persistent lack of ...

Data presented at ATS 2025 showed that lung improvement in paediatric cystic fibrosis (CF) patients receiving ETI therapy is ...

Skye has entered a partnership with Arecor aimed at developing a higher formulation of the former’s obesity candidate, ...

The agreement will see international initiatives to fight the next pandemic, but funding remains the weak link.

The Japanese MHLW has granted approval for the use of GSK’s Blenrep (belantamab mafodotin) combinations for MM.

Novotech is a winner in the Diversity, Research and Development, and Marketing categories in the 2025 Pharmaceutical ...

An ATS 2025 session presented data showing that anti–IL-5 biologics significantly cut exacerbations in coexisting asthma and ...